VBI Vaccines Inc (NASDAQ:VBIV)
| 2.19 Delayed Data As of 3:59pm ET |  -0.20 / -8.37%Today’s Change | 2.09 Today|||52-Week Range 4.83 | -20.36% Year-to-Date |
Latest VBIV News | Press Releases
| Why Vaccine Stocks Like BioNTech and Novavax Are Crashing Today 4:19pm / MotleyFool.com - Paid Partner Content | Implied Volatility Surging for VBI Vaccines (VBIV) Stock Options Nov 29 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 2.39 |
| Today’s open | 2.67 |
| Day’s range | 2.15 - 2.69 |
| Volume | 407,691 |
| Average volume (3 months) | 2,759,894 |
| Market cap | $697.3M |
Data as of 3:59pm ET, 12/06/2021
Growth & Valuation
| Earnings growth (last year) | +53.85% |
| Earnings growth (this year) | -30.16% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -52.23% |
| P/E ratio | NM |
| Price/Sales | 565.73 |
| Price/Book | 3.90 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BTAIBioXcel Therapeutics... | -0.48 | -2.24% |
| CARACara Therapeutics In... | -0.16 | -1.30% |
| SIGASIGA Technologies In... | -0.31 | -4.05% |
| ADAPAdaptimmune Therapeu... | +0.02 | +0.56% |
Data as of 4:43pm ET, 12/06/2021
Financials
| Next reporting date | February 28, 2022 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | $1.1M |
| Annual profit (last year) | -$46.2M |
| Net profit margin | -4,357.21% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
